Research & Development



  “聞听主爵都尉一向剛烈,眼楮里從來容不下沙子,遇事定要分辯出一個真偽。此次為何悄然無聲?”   劉徹冷冰冰的將最深情的告白說完之後,就從葡萄釀里撈出一支冰魚,丟進嘴里咬的咯吱咯吱的。超碰最新   蘭喬也笑嘻嘻的從山坡上跑下來,看到大奶羊沉甸甸的乳房就要把小狗子往大奶羊的肚子底下送,瞅著兒子起勁的吸吮,狗子一臉的無奈。超碰公开免费视频   阿嬌弱弱的道︰“擦干淨,您一會還要坐這。” 超碰免费视频在线观看   從明天起,他們就要投入到一種未知的生活狀態中去,沒人能夠保證他們可以平安的抵達長安……

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo